Sensus Healthcare, Inc. (SRTS) Financial Ratios
12 years of historical data (2014–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
N/A
—
5yr avg: 60.55
30Y Low6.4·High22.2
P/FCF
203.79
+4% vs avg
5yr avg: 195.73
30Y Low195.7·High195.7
P/B Ratio
↓
1.40
↓-38% vs avg
5yr avg: 2.26
30Y Low0.8·High5.8
ROE
↓
-14.9%
↑-191% vs avg
5yr avg: 16.3%
30Y Low-89%·High65%
Debt/EBITDA
↑
N/A
—
5yr avg: 2.52
30Y Low0.0·High9.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SRTS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Sensus Healthcare, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 203.8x P/FCF, roughly in line with the 5-year average of 195.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $68M | $65M | $113M | $38M | $123M | $119M | $63M | $57M | $105M | $68M | $63M |
| Enterprise Value | $46M | $44M | $92M | $16M | $99M | $105M | $50M | $51M | $92M | $60M | $58M |
| P/E Ratio → | -8.74 | — | 16.88 | 79.19 | 5.08 | 28.88 | — | — | — | — | — |
| P/S Ratio | 2.46 | 2.36 | 2.71 | 1.57 | 2.77 | 4.41 | 6.62 | 2.11 | 3.96 | 3.32 | 4.26 |
| P/B Ratio | 1.40 | 1.35 | 2.03 | 0.79 | 2.57 | 4.58 | 2.95 | 2.05 | 3.95 | 5.85 | 4.13 |
| P/FCF | 203.79 | 195.73 | — | — | — | — | — | — | — | — | — |
| P/OCF | 128.14 | 123.07 | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
SRTS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.59 | 2.19 | 0.66 | 2.22 | 3.88 | 5.21 | 1.86 | 3.49 | 2.94 | 3.92 |
| EV / EBITDA | — | — | 10.77 | 202.82 | 6.44 | 22.15 | — | — | — | — | — |
| EV / EBIT | — | — | 11.34 | — | 6.66 | 25.44 | — | — | — | — | — |
| EV / FCF | — | 131.26 | — | — | — | — | — | — | — | — | — |
SRTS Profitability
Margins and return-on-capital ratios measuring operating efficiency
Sensus Healthcare, Inc. earns an operating margin of -37.5%. Operating margins have compressed from -1.6% to -37.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -14.9% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.2% | 58.4% | 57.6% | 66.5% | 62.8% | 54.8% | 64.4% | 64.0% | 67.0% | 66.5% |
| Operating Margin | -37.5% | -37.5% | 19.4% | -1.6% | 33.3% | 15.2% | -86.0% | -7.2% | -7.6% | -18.1% | -2.5% |
| Net Profit Margin | -28.1% | -28.1% | 15.9% | 2.0% | 54.4% | 15.2% | -71.4% | -6.2% | -7.7% | -18.0% | -2.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.9% | -14.9% | 12.7% | 1.0% | 65.5% | 17.3% | -27.6% | -6.2% | -10.6% | -27.5% | -3.3% |
| ROA | -13.4% | -13.4% | 11.5% | 0.9% | 54.5% | 13.7% | -21.1% | -4.8% | -7.8% | -19.6% | -2.4% |
| ROIC | -25.3% | -25.3% | 19.9% | -1.1% | 63.0% | 31.4% | -42.2% | -8.4% | -16.9% | -39.7% | -4.7% |
| ROCE | -19.7% | -19.7% | 15.3% | -0.8% | 39.4% | 16.7% | -30.7% | -6.8% | -10.3% | -27.5% | -3.4% |
SRTS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $22M exceeds total debt of $680000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.06 | 0.05 | — | 0.19 | — |
| Debt / EBITDA | — | — | 0.07 | 9.91 | 0.07 | 0.05 | — | — | — | — | — |
| Net Debt / Equity | — | -0.44 | -0.38 | -0.46 | -0.51 | -0.55 | -0.63 | -0.24 | -0.47 | -0.67 | -0.33 |
| Net Debt / EBITDA | — | — | -2.52 | -283.10 | -1.60 | -3.02 | — | — | — | — | — |
| Debt / FCF | — | -64.47 | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | 7415.50 | 4121.00 | -487.29 | — | -11.91 | -52.87 | -14.84 |
Net cash position: cash ($22M) exceeds total debt ($680000)
SRTS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Sensus Healthcare, Inc.'s current ratio of 9.72x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 6.63x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 11.76x to 9.72x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.72 | 9.72 | 9.64 | 11.76 | 6.92 | 5.24 | 5.18 | 5.26 | 5.30 | 2.53 | 4.58 |
| Quick Ratio | 6.63 | 6.63 | 7.93 | 8.94 | 6.46 | 4.94 | 4.27 | 4.79 | 5.03 | 2.36 | 4.24 |
| Cash Ratio | 4.68 | 4.68 | 3.75 | 5.50 | 3.32 | 2.43 | 3.07 | 2.39 | 2.55 | 1.58 | 3.15 |
| Asset Turnover | — | 0.52 | 0.67 | 0.45 | 0.78 | 0.84 | 0.34 | 0.74 | 0.79 | 1.09 | 0.78 |
| Inventory Turnover | 1.07 | 1.07 | 1.72 | 0.87 | 4.26 | 5.72 | 0.98 | 3.24 | 5.84 | 5.79 | 3.96 |
| Days Sales Outstanding | — | 80.23 | 172.26 | 159.21 | 141.79 | 163.72 | 143.91 | 187.58 | 181.57 | 87.90 | 76.36 |
SRTS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Sensus Healthcare, Inc. returns 0.4% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | 4.0% |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 5.9% | 1.3% | 19.7% | 3.5% | — | — | — | — | — |
| FCF Yield | 0.5% | 0.5% | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.4% | 0.5% | 0.0% | 0.1% | 2.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% |
| Total Shareholder Yield | 0.4% | 0.5% | 0.0% | 0.1% | 2.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 4.0% |
| Shares Outstanding | — | $16M | $16M | $16M | $17M | $17M | $16M | $16M | $14M | $13M | $12M |
Peer Comparison
Compare SRTS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SRTSYou | $68M | -8.7 | — | 203.8 | 43.2% | -37.5% | -14.9% | -25.3% | — |
 XTLB | $293767 | -0.3 | — | — | 0.7% | -481.6% | -26.8% | -54.1% | — |
 STXS | $177M | -6.3 | — | — | 54.2% | -91.9% | -144.2% | -289.6% | — |
 ARAY | $35M | -18.9 | 11.0 | — | 32.1% | 1.7% | -2.5% | 3.0% | 12.6 |
 ISRG | $161B | 57.6 | 43.6 | 64.7 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 GKOS | $8B | -40.9 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 EW | $48B | 45.2 | 25.4 | 35.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ABT | $151B | 11.4 | 15.8 | 23.8 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 12 years · Updated daily
See SRTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SRTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SRTS vs XTLB
Side-by-side business, growth, and profitability comparison vs XTL Biopharmaceuticals Ltd..
Start ComparisonSRTS — Frequently Asked Questions
Quick answers to the most common questions about buying SRTS stock.
What is Sensus Healthcare, Inc.'s P/E ratio?
Sensus Healthcare, Inc.'s current P/E ratio is -8.7x. The historical average is 32.5x.
What is Sensus Healthcare, Inc.'s ROE?
Sensus Healthcare, Inc.'s return on equity (ROE) is -14.9%. The historical average is -7.3%.
Is SRTS stock overvalued?
Based on historical data, Sensus Healthcare, Inc. is trading at a P/E of -8.7x. Compare with industry peers and growth rates for a complete picture.
What are Sensus Healthcare, Inc.'s profit margins?
Sensus Healthcare, Inc. has 43.2% gross margin and -37.5% operating margin.